| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 14 |
| 1 | IBUPFROFEN | 13 |
| 2 | IBUPROFEN | 13 |
| 3 | IBUPROFEN 200 MG | 13 |
| 4 | IBUPROFEN 200MG | 13 |
| 5 | IBUPROFEN CAPSULE | 13 |
| 6 | IBUPROFEN CAPSULES 200 MG | 13 |
| 7 | IBUPROFEN ORAL | 13 |
| 8 | IBUPROFEN TABLET, FILM COATED | 13 |
| 9 | IBUPROFEN TABLET, FILM-COATED | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NITROGEN | 1 | 0.0090 |
| 1 | NATALIZUMAB-SZTN | 1 | 0.0042 |
| 2 | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | 2 | 0.0012 |
| 3 | PEPPERMINT OIL | 1 | 0.0009 |
| 4 | DANTROLENE SODIUM | 1 | 0.0009 |
| 5 | NORETHINDRONE AND ETHINYL ESTRADIOL | 1 | 0.0009 |
| 6 | IDARUCIZUMAB | 1 | 0.0007 |
| 7 | TALIMOGENE LAHERPAREPVEC | 1 | 0.0006 |
| 8 | DICHLORPHENAMIDE | 1 | 0.0006 |
| 9 | INFLIXIMAB-DYYB | 2 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 34 |
| 1 | Corticosteroid [EPC] | 32 |
| 2 | Platinum-based Drug [EPC] | 17 |
| 3 | Benzodiazepine [EPC] | 13 |
| 4 | Fluoroquinolone Antibacterial [EPC] | 13 |
| 5 | HMG-CoA Reductase Inhibitor [EPC] | 12 |
| 6 | Xanthine Oxidase Inhibitor [EPC] | 12 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 11 |
| 8 | Factor Xa Inhibitor [EPC] | 10 |
| 9 | Loop Diuretic [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 1 | Humanized Monoclonal Antibody Fragment [EPC] | 1 | 0.0007 |
| 2 | Rifamycin Antimycobacterial [EPC] | 1 | 0.0003 |
| 3 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 3 | 0.0002 |
| 4 | Catechol-O-Methyltransferase Inhibitor [EPC] | 1 | 0.0002 |
| 5 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 6 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 7 | Fluoroquinolone Antibacterial [EPC] | 13 | 0.0001 |
| 8 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 9 | Catecholamine [EPC] | 7 | 0.0001 |